SALL2 and central nervous system cancer: METTL3 is also upregulated in glioblastoma, and silence of METTL3 inhibits the growth of glioma stem cells by downregulating POU3F2, SOX2, SALL2, OLIG2, and other glioma recombinant factors [23].